HighCape Capital Acquisition Corp. Cl A (CAPA) News
Filter CAPA News Items
CAPA News Results
|Loading, please wait...|
CAPA News Highlights
- 500 - Internal server error
- Over the past 8 days, the trend for CAPA's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- SI are the most mentioned tickers in articles about CAPA.
Latest CAPA News From Around the Web
Below are the latest news stories about HighCape Capital Acquisition Corp that investors may wish to consider to help them evaluate CAPA as an investment opportunity.
Quantum-Si, Revolutionizing Proteomics, Closes Business Combination and Will Begin Trading Under the Ticker "QSI" on the Nasdaq Stock Exchange
Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSi" or "the Company"), a company pioneering next-generation semiconductor chip-based proteomics, today announced that it has completed its business combination with HighCape Capital Acquisition Corp. (Nasdaq: CAPA) ("HighCape"), a special purpose acquisition company sponsored by leading healthcare growth equity manager HighCape Capital LP. The business combination and concurrent private placement, which were approved by HighCape’s stockholde
HighCape Capital Acquisition Corp. Reminds Stockholders to Vote in Favor of the Business Combination with Quantum-Si Incorporated
NEW YORK, June 02, 2021 (GLOBE NEWSWIRE) -- HighCape Capital Acquisition Corp. (Nasdaq: CAPA) (“HighCape”), a special purpose acquisition company sponsored by leading healthcare growth equity investment firm HighCape Capital LP, reminds its stockholders of record as of the close of business on May 10, 2021 to vote at the upcoming special meeting of stockholders held virtually at https://www.cstproxy.com/highcape/sm2021 on June 9, 2021 at 10:00 a.m. Eastern Time (the “Special Meeting”) to approve
Quantum-Si and HighCape Capital Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business Combination
Special meeting of HighCape stockholders scheduled for June 9, 2021NEW YORK and GUILFORD, Conn., May 17, 2021 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, and HighCape Capital Acquisition Corp. (“HighCape”), a healthcare-focused special purpose acquisition company (SPAC), today announced that the Securities and Exchange Commission (“SEC”) has declared the Registration Statement on Form S-4 in connection with the proposed business combination between the two companies, to be effective. A special meeting of HighCape stockholders (the "Special Meeting") to approve, among other things, the proposed business combination, will be held in virtual format on June 9, 2021 at 10:00 a.m. Eastern Time. HighCape also announced ...
Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, announced today the appointment of Marijn Dekkers, Ph.D. and Ruth Fattori to its Board of Directors. Both Dr. Dekkers and Ms. Fattori have agreed to continue to serve on the Board of Directors of the combined company subsequent to the closing of the previously announced business combination between Quantum-Si and HighCape Capital Acquisition Corp (Nasdaq: CAPA).
Quantum-Si Incorporated, a pioneer in next-generation semiconductor chip-based proteomics, announced today the appointment of Claudia Napal Drayton as Chief Financial Officer.
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of HighCape Capital Acquisition Corp. (NASDAQ:CAPA)
BALA CYNWYD, PA / ACCESSWIRE / February 22, 2021 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of HighCape Capital Acquisition Corp. ("HighCape" or the "Company") (NASDAQ:CAPA) for possible breaches of fiduciary duty and other violations of federal and state law in connection with a merger agreement pursuant to which HighCape, a special purpose acquisition company, will combine with Quantum-Si Incorporated ("Quantum-Si"), a pioneer in next generation semiconductor chip-based proteomics, and result in Quantum-Si becoming a publicly-listed company.
Ark Invest Backs SPAC Merger For Quantum-Si, A Company Founded By Butterfly Network's Jonathan Rothberg
A SPAC deal announced Thursday will see a company working on a new protein sequencing on a chip go public. The SPAC Deal: Semiconductor company Quantum-Si is going public in a SPAC merger with HighCape Capital Acquisition Corp (NASDAQ: CAPA). The deal values Quantum-Si at $925 million. An oversubscribed PIPE of $425 million included investment from accounts advised by Ark Invest, the firm led by Cathie Wood. PIPE investors will own 29.1% of the company after the merger. Shares will trade as "QSI" on the Nasdaq if the merger is approved. Current HighCape Capital Acquisition shareholders will own 7.9% of the new company. About Quantum-Si: Planning to launch a chip-based proteomics solution, Quantum-Si believes it can change the protein and genomics markets. Quantum-Si created the first ne...
Quantum-Si, a Pioneer in Semiconductor Chip-Based Proteomics, to Combine with HighCape Capital Acquisition Corp.
The transaction will merge Quantum-Si’s revolutionary, end-to-end proteomics solution, and HighCape Capital Acquisition Corp., a healthcare-focused SPAC sponsored by leading healthcare growth equity investment firm HighCape Capital LP.The transaction is further supported by an oversubscribed $425 million PIPE with participation from leading institutional investors, including Foresite Capital Management, LLC, Eldridge, accounts advised by ARK Invest, Glenview Capital Management, LLC, and Redmile Group, LLC.The pro forma equity value of the business combination is $1.460 billion, with the combined company expected to have an estimated $514 million in cash after closing.Quantum-Si Founder and Executive Chairman, Dr. Jonathan Rothberg, to become Executive Chairman of the combined company an...